Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Colonic Neoplasms 10Stomach Neoplasms 3Rectal Neoplasms 3Carcinoma, Hepatocellular 3Neoplastic Cells, Circulating 2Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Ulcer 1Prostatic Neoplasms 1Polyps 1Patient Satisfaction 1Pancreatic Neoplasms 1Pain, Postoperative 1Overweight 1Ovarian Neoplasms 1Obesity 1Melanoma 1Hypoxia 1Esophageal Neoplasms 1Endobronchial Metastases 1Emergence Delirium 1Diverticulosis, Colonic 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

remimazolam 1Sufentanil 1Ropivacaine 1Propofol 1Neuroleptanalgesia 1Minocycline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Emergence Delirium × Propofol × Gastrointestinal × Clear all
NCT07351474 2026-01-20

Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy

The First Affiliated Hospital with Nanjing Medical University

Phase NA Not yet recruiting
170 enrolled
Gastrointestinal

Emergence Delirium, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡